Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, USA.
Center for Infectious Diseases Research in Africa (CIDRI-Africa) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town, 7925, South Africa.
Sci Rep. 2024 Oct 9;14(1):23595. doi: 10.1038/s41598-024-71180-1.
Formyl peptide receptors (FPR), part of the G-protein coupled receptor superfamily, are pivotal in directing phagocyte migration towards chemotactic signals from bacteria and host tissues. Although their roles in acute bacterial infections are well-documented, their involvement in immunity against tuberculosis (TB) remains unexplored. Here, we investigate the functions of Fpr1 and Fpr2 in defense against Mycobacterium tuberculosis (Mtb), the causative agent of TB. Elevated levels of Fpr1 and Fpr2 were found in the lungs of mice, rabbits and peripheral blood of humans infected with Mtb, suggesting a crucial role in the immune response. The effects of Fpr1 and Fpr2 deletion on bacterial load, lung damage, and cellular inflammation were assessed in a murine TB model utilizing hypervirulent strain of Mtb from the W-Beijing lineage. While Fpr2 deletion had no impact on disease outcome, Fpr1-deficient mice demonstrated improved bacterial control, especially by macrophages. Bone marrow-derived macrophages from these Fpr1 mice exhibited an enhanced ability to contain bacterial growth over time. Contrarily, treating genetically susceptible mice with Fpr1-specific inhibitors caused impaired early bacterial control, corresponding with increased Mtb persistence in necrotic neutrophils. Furthermore, ex vivo assays revealed that Fpr1 neutrophils were unable to restrain Mtb growth, indicating a differential function of Fpr1 among myeloid cells. These findings highlight the distinct and complex roles of Fpr1 in myeloid cell-mediated immunity against Mtb infection, underscoring the need for further research into these mechanisms for a better understanding of TB immunity.
形式肽受体(FPR)是 G 蛋白偶联受体超家族的一部分,在引导吞噬细胞向细菌和宿主组织的趋化信号迁移方面起着关键作用。尽管它们在急性细菌感染中的作用已得到充分证实,但它们在结核病(TB)免疫中的作用仍未得到探索。在这里,我们研究了 Fpr1 和 Fpr2 在防御结核分枝杆菌(Mtb)中的作用,Mtb 是结核病的病原体。在感染 Mtb 的小鼠、兔子的肺部和人类外周血中发现 Fpr1 和 Fpr2 水平升高,表明它们在免疫反应中起着至关重要的作用。在利用来自 W-Beijing 谱系的高毒力 Mtb 株的小鼠 TB 模型中,评估了 Fpr1 和 Fpr2 缺失对细菌负荷、肺部损伤和细胞炎症的影响。虽然 Fpr2 缺失对疾病结局没有影响,但 Fpr1 缺陷小鼠显示出更好的细菌控制能力,尤其是巨噬细胞。来自这些 Fpr1 小鼠的骨髓来源的巨噬细胞表现出随着时间的推移增强的控制细菌生长的能力。相反,用 Fpr1 特异性抑制剂治疗遗传易感小鼠会导致早期细菌控制受损,同时坏死中性粒细胞中 Mtb 持续存在增加。此外,体外实验表明,Fpr1 中性粒细胞无法抑制 Mtb 的生长,表明 Fpr1 在髓样细胞介导的抗 Mtb 感染免疫中具有不同的功能。这些发现强调了 Fpr1 在髓样细胞介导的抗 Mtb 感染免疫中的独特而复杂的作用,突显了进一步研究这些机制以更好地理解 TB 免疫的必要性。